Ferro-Alloy Resources Balasausqandiq study confirms world-class cost advantage (LON:FAR) 20 October 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Ferro-Alloy Resources Unveils Compelling Potential Following Robust Feasibility Study (LON:FAR) – Panmure Liberum 17 October 2025
Berkeley Group posts £254 million profit and maintains strong cash position in interim results 10 December 2025
Workspace Group PLC (WKP.L) Stock Analysis: A High-Yield Opportunity with Strategic Flexibility 2 January 2026
WH Smith PLC (SMWH.L) Stock Analysis: Navigating the Consumer Cyclical Waves with a Promising 20.89% Upside 2 January 2026
Urban Logistics REIT plc (SHED.L) Stock Analysis: Navigating Through a Data-Deficient Terrain 2 January 2026
Ferro-Alloy Resources Balasausqandiq study confirms world-class cost advantage (LON:FAR) 20 October 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Ferro-Alloy Resources Unveils Compelling Potential Following Robust Feasibility Study (LON:FAR) – Panmure Liberum 17 October 2025
Berkeley Group posts £254 million profit and maintains strong cash position in interim results 10 December 2025
Workspace Group PLC (WKP.L) Stock Analysis: A High-Yield Opportunity with Strategic Flexibility 2 January 2026
WH Smith PLC (SMWH.L) Stock Analysis: Navigating the Consumer Cyclical Waves with a Promising 20.89% Upside 2 January 2026
Urban Logistics REIT plc (SHED.L) Stock Analysis: Navigating Through a Data-Deficient Terrain 2 January 2026
Immunome, Inc. (IMNM) Stock Analysis: Evaluating the 59% Potential Upside in Biotech Innovation 2 January 2026
Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: Exploring a 126.63% Potential Upside 2 January 2026
Talkspace, Inc. (TALK) Stock Analysis: Potential 33.81% Upside as Digital Healthcare Expands 2 January 2026
Investor Outlook: Amylyx Pharmaceuticals (AMLX) Offers 67.4% Upside Potential Amid Strong Buy Ratings 2 January 2026
Savara, Inc. (SVRA) Stock Analysis: Biotech’s 79% Potential Upside Ignites Investor Interest 2 January 2026
Nurix Therapeutics, Inc. (NRIX) Stock Analysis: A Biotech Contender with a 49.77% Upside Potential 2 January 2026
AbCellera Biologics Inc. (ABCL): Investor Outlook with a Robust 187.52% Potential Upside 2 January 2026
Nuvation Bio Inc. (NUVB) Stock Analysis: Unpacking the 1,704.70% Revenue Growth and 25.56% Potential Upside 2 January 2026
Valneva SE (VALN) Stock Analysis: Exploring a 46.12% Potential Upside in the Biotech Sector 2 January 2026
Phibro Animal Health Corporation (PAHC) Stock Analysis: Exploring a 15% Upside Potential and Robust Revenue Growth 2 January 2026
uniQure N.V. (QURE) Stock Analysis: Unveiling a 131% Potential Upside in the Biotech Sector 2 January 2026
Butterfly Network, Inc. (BFLY) Investor Outlook: Exploring a 10.20% Upside Potential with Strong Buy Ratings 2 January 2026
Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Unveiling a 76% Potential Upside in the Biotech Sector 2 January 2026
Relay Therapeutics, Inc. (RLAY) Stock Analysis: Unpacking the 72.58% Potential Upside in Precision Medicine 2 January 2026
Zenas BioPharma, Inc. (ZBIO) Stock Analysis: A Promising 34.95% Upside in the Biotech Arena 2 January 2026
RxSight, Inc. (RXST) Investor Outlook: Navigating the Ups and Downs in the Medical Devices Market 2 January 2026
AxoGen, Inc. (AXGN) Stock Analysis: A Promising 8% Potential Upside in the Healthcare Sector 2 January 2026
Dianthus Therapeutics, Inc. (DNTH): Investor Outlook on a Biotech with 52.99% Potential Upside 2 January 2026
Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Unlocking a 77% Potential Upside in Healthcare 2 January 2026
Gattaca: AI-Driven Growth, Strategic Focus and Why FY26 Could Be a Breakout Year (Video) 24 October 2025
Ilika plc Goliath Pilot Line Now Fully Operational, Paving the Road to Licensing Deals (Video) 22 October 2025
Volta Finance: How Retail Investors Can Tap Into Private Credit’s Hottest Corner (Video) 21 October 2025
Thor Energy Strategic Shake-Up Yields $9M and Clears Path for Hydrogen & Helium Boom (Video) 15 October 2025
Ferro-Alloy Resources: Vanadium Giant Unveils Feasibility Win and Massive Phase Two Upside (Video) 14 October 2025
Why Real Estate Credit Investments’ Resilience Could Be an Investor’s Hidden Advantage (Video) 13 October 2025
Smith & Nephew outlines RISE strategy with upgraded guidance and new 2028 financial targets 8 December 2025
Harbour Energy to sell Indonesian Natuna Sea Block A and Tuna project for $215 million 8 December 2025
Ferro-Alloy Resources Balasausqandiq study confirms world-class cost advantage (LON:FAR) 20 October 2025
Ferro-Alloy Resources Unveils Compelling Potential Following Robust Feasibility Study (LON:FAR) – Panmure Liberum 17 October 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Workspace Group PLC (WKP.L) Stock Analysis: A High-Yield Opportunity with Strategic Flexibility 2 January 2026
WH Smith PLC (SMWH.L) Stock Analysis: Navigating the Consumer Cyclical Waves with a Promising 20.89% Upside 2 January 2026
Urban Logistics REIT plc (SHED.L) Stock Analysis: Navigating Through a Data-Deficient Terrain 2 January 2026
